U.S. Markets closed

TapImmune, Inc. (TPIV)

NasdaqCM - NasdaqCM Delayed Price. Currency in USD
Add to watchlist
3.38+0.48 (+16.55%)
At close: 4:00PM EDT
People also watch
AVXLPPCHSNGXPSIDADXS
Full screen
Previous Close2.90
Open2.90
Bid0.00 x 0
Ask0.00 x 0
Day's Range2.87 - 3.39
52 Week Range2.68 - 7.15
Volume14,691
Avg. Volume42,296
Market Cap34.34M
Beta-1.09
PE Ratio (TTM)-8.54
EPS (TTM)N/A
Earnings DateN/A
Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • Benzinga4 months ago

    Drug Trials Heating Up In The Breast and Ovarian Cancer Treatment Space

    The next generation of breast and ovarian cancer treatment is attacking the deadly disease from all angles. That is no more evident than in the glut of pharmaceutical companies racing to develop, test, ...

  • TapImmune, Inc. :TPIV-US: Earnings Analysis: Q3, 2015 By the Numbers
    Capital Cubelast year

    TapImmune, Inc. :TPIV-US: Earnings Analysis: Q3, 2015 By the Numbers

    Click here to see latest analysisTapImmune, Inc. reports financial results for the quarter ended September 30, 2015.AnalysisSummary numbers: Revenues of USD 0 million, Net Earnings of USD 2.48 million.The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless.TPIV-US‘s book value of equity is […] (Read more...) The post TapImmune, Inc. :TPIV-US: Earnings Analysis: Q3, 2015 By the Numbers appeared first on CapitalCube.

  • Capital Cube2 years ago

    TapImmune, Inc. Earnings Q2, 2015

    TapImmune, Inc. reports preliminary financial results for the quarter ended June 30, 2015.We analyze the earnings along side the following peers of TapImmune Inc. – Newlink Genetics Corporation, Progenics Pharmaceuticals, Inc., United Therapeutics Corporation, Opexa Therapeutics, Inc., Aeterna Zentaris Inc., Mirati Therapeutics Inc. and Sophiris Bio Inc. (NLNK-US, PGNX-US, UTHR-US, OPXA-US, AEZS-US, MRTX-US and SPHS-US) (Read more...) The post TapImmune, Inc. Earnings Q2, 2015 appeared first on CapitalCube.